randomized, controlled single center, single investigator study mainly in colorectal screening population in daily practice with and without artificial intelliegence (AI) named DiscoveryTM from Pentax medical. Patient randomly are allocated to one of four groups: Pentax i10 colonoscopes without any additional device, Pentax i 10 with DiscoveryTM (AI), Pentax i 10 with EndocuffTM and Pentax i10 with EndocuffTM and DiscoveryTM (AI). The different groups are compared in terms of the different parameters: e.g. time of endoscopy, polyps (PDR) and adenoma detected (ADR).
From August 2021 through August 2022 all patients undergoing a colonoscopy in a gastroenterologist's private practice are assigned using randomization tables to one or the other above mentioned groups. Time of the endoscopy (ascent, descent and intervention time), polyps detected and their histology are written down real time with a tablet computer anonymized with the patient number. Furthermore dosage of sedatives and over all satisfaction is traced. 1. endpoint is time gain in the different phase of the colonoscopy 2. endpoint is adenoma detection rate (ADR)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
1,100
on the monitor artificial integlligence Discovery can be switched on or off.
Martin Geyer
Wettingen, Canton of Aargau, Switzerland
Endoscopy time
measurement of ascent, descent and intervention time during colonoscopy
Time frame: within 45 minutes of examination
polyp and adenoma detetction rate PDR and ADR
counts of polypes and their location in the colon and their histology
Time frame: within 45 minutes of examination
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.